The bill was one of several discussed during a Thursday hearing by the Health Subcommittee of the House of Representatives' ...

The companies will work to integrate Prevencio's protein-based blood tests into Quadrant's care pathways to better translate the results into clinical action and measure outcomes.

NEW YORK — Alpenglow Biosciences has partnered with digital pathology lab PathNet to develop 3D pathology-based diagnostics for prostate and bladder cancers, the companies said on Thursday.

Coupling biomarker-guided screening with a targeted treatment bundle reduced newborn mortality, hospital stays, and other complications over standard care, according to a recent study.

The funding will support final development, clinical validation, regulatory approval, and commercial launch of an ultra-rapid AST platform.

Fox Chase will use Arima's 3D genomics technology as part of its diagnostic workflow for lymphoma and sarcoma.